All News

How would you like to have to go back for 10 years and figure out if the feds have overpaid you on a Medicare or Medicaid claim and then be required to pay up within 60 days or face monetary penalties and maybe get kicked out of federal health care programs? That's exactly what will happen unless a regulation proposed by the Centers for Medicare & Medicaid Services is significantly revised.

The Urologic Diseases in America research initiative, last published in 2007, has been revised and updated for 2012 to include new, detailed information on the utilization of resources and the costs associated with urologic diseases among men, women, and children.

Treatment of early-stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms, according to results from a multicenter study presented at the AUA annual meeting in Atlanta.

The autologous cellular immunotherapy sipuleucel-T (Provenge) appears to demonstrate an overall survival benefit in patients with advanced prostate cancer, according to two studies presented at the AUA annual meeting in Atlanta.

When the initial wide incision of a microdissection testicular sperm extraction procedure reveals no sperm-containing tubules, there is a 35% chance of finding sperm with a deeper, more extensive exploration, according to a 10-year study of 900 men with nonobstructive azoospermia.

Researchers teasing out the relationship between urinary tract infection and its symptoms are zeroing in on the major component of Escherichia coli's cell wall, lipopolysaccharide (LPS), as the culprit.

Phosphodiesterase type-5 inhibitors are safe and effective, alone or in combination with alpha-blockers, against lower urinary tract symptoms (LUTS) secondary to BPH, according to a systematic review and meta-analysis.

In phase II results presented here yesterday, the investigational beta3-adrenoceptor agonist solabegron yielded statistically significant improvements in symptoms of overactive bladder compared to placebo and was safe and well tolerated, Dutch researchers reported.

In the hands of high-volume surgeons, there is no evidence to suggest that robot-assisted laparoscopic prostatectomy (RALP) results in worse oncologic outcomes than open radical prostatectomy, even for patients with high-risk cancer, according to a retrospective study of patients operated on at a large tertiary care center.

Despite its well-established advantages over radical surgery, partial nephrectomy is not as likely to be used for older, sicker, and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, researchers from Henry Ford Hospital, Detroit reported here yesterday.

Juan A. Reyna, MD, who has served as president and CEO of Urology San Antonio for 16 years, has stepped down as the leader of the 29-physician group. He will continue to work as a urologist at the medical practice.